# Advanced Enzyme Technologies Ltd (ADVENZYMES)
> Exchange: NSE | Sector: Chemicals | ISIN: 

## Price
Current Price: ₹386.2
Day Change: -0.69%
52W High: ₹419
52W Low: ₹251.95
Market Cap: ₹4,073 Cr

## Valuation
P/E: 26.75
P/B: 2.74
EPS: ₹13.6
Book Value: ₹132.6
Dividend Yield: 0%

## Returns
1Y Return: 9.94%

## Profitability
ROE: 0%
ROCE: 14.33%
Debt/Equity: 0.02
Revenue Growth: 1.7%
Profit Growth: 12.8%
EBITDA Margin: 27.91%
Operating Margin: 22.76%

## About
Advanced Enzyme Technologies Ltd is a Specialty Chemicals company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Chemicals
Industry: Specialty Chemicals
Sub Industry: Unknown

## Business Model
Overview: Advanced Enzyme Technologies Ltd makes money through Manufactured commodity sales, Value-added products, Exports or institutional demand in Specialty Chemicals. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Chemicals.
Source: Derived from stock data
Revenue Streams:
- Manufactured commodity sales
- Value-added products
- Exports or institutional demand
Operating Model:
- Uses plants, mines, or processing assets to convert raw materials into industrial products.
- Realisation, utilisation, energy cost, logistics, and commodity cycles drive earnings.
Recent Context:
- Concall Transcript: Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- GuruFocus.com: Advanced Enzyme Technologies Ltd (BOM:540025) Q4 2026 Earnings Call Highlights: Record Revenue ...

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:00.502Z
Price History Updated: 2026-05-17T21:23:54.214Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:23:54.214Z
Quant Updated: 2026-05-17T21:23:54.214Z
Sentiment Updated: 2026-05-17T21:23:54.214Z
Financials Status: current
Financials Updated: 2026-05-18T13:32:11.921Z
Financials Last Attempt: 2026-05-18T13:32:11.921Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2016)
Revenue: ₹222 Cr
Operating Profit: ₹91 Cr (OPM 41%)
Net Profit: ₹51 Cr
Tax: ₹74 Cr

## Annual P&L History
Mar 2016: Rev ₹222Cr | PAT ₹51Cr | OPM 41%
Mar 2017: Rev ₹293Cr | PAT ₹77Cr | OPM 47%
Mar 2018: Rev ₹329Cr | PAT ₹93Cr | OPM 46%

## Balance Sheet (Mar 2016)
Total Assets: ₹417 Cr
Total Liabilities: ₹417 Cr
Borrowings: ₹115 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Beni Prasad Rauka CA, Chief Financial Officer
- Sanjay Prakash Basantani, Company Secretary, Head of Legal & Compliance Officer
- Bhaskar  Manolkar, General Manager of Human Resources & Administration
- Ronak  Saraf, Investor Relations Manager
- Michael  Puls, MD & Head of Research and Development - evoxx technologies GmbH

---
Source: rupiya.io/stocks/advenzymes
Disclaimer: For research and education only. Not investment advice.